Iron has been shown to preferentially accumulate in lung cancer tissue, as these tumors have a phenotype characterized by increased iron import through the transferrin receptor (TfR), altered iron regulatory protein (IRP1/2) activity, and decreased iron export through ferroportin [4,7,8,9]. Here, TFRC is linked to lung carcinoma.